GlassScriptPhysician profile
Deepak Chandramohan
NPI 1942598388
$942.21
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $310 · 2020: $371 · 2021: $248 · 2022: $13.10.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $474.67 | 2019-2021 | |
| Philips North America LLC | $170.47 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $82.89 | 2020 | |
| Pfizer INC. | $66.65 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $55.41 | 2019 | |
| Gilead Sciences, INC. | $37.07 | 2021 | |
| Merck Sharp & Dohme LLC | $32.34 | 2019-2020 | |
| Eisai INC. | $22.71 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepak Chandramohan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.